Literature DB >> 9516123

Erythroid Krüppel-like factor is essential for beta-globin gene expression even in absence of gene competition, but is not sufficient to induce the switch from gamma-globin to beta-globin gene expression.

L G Guy1, Q Mei, A C Perkins, S H Orkin, L Wall.   

Abstract

Different genes in the beta-like globin locus are expressed at specific times during development. This is controlled, in part, by competition between the genes for activation by the locus control region. In mice, gene inactivation of the erythroid Krüppel-like factor (EKLF) transcription factor results in a lethal anemia due to a specific and substantial decrease in expression of the fetal/adult-stage-specific beta-globin gene. In transgenic mice carrying the complete human beta-globin locus, EKLF ablation not only impairs human beta-globin-gene expression but also results in increased expression of the human gamma-globin genes during the fetal/adult stages. Hence, it may appear that EKLF is a determining factor for the developmental switch from gamma-globin to beta-globin transcription. However, we show here that the function of EKLF for beta-globin-gene expression is necessary even in absence of gene competition. Moreover, EKLF is not developmental specific and is present and functional before the switch from gamma-globin to beta-globin-gene expression occurs. Thus, EKLF is not the primary factor that controls the switch. We suggest that autonomous repression of gamma-globin transcription that occurs during late fetal development is likely to be the initiating event that induces the switch.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516123

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

1.  Non-random subcellular distribution of variant EKLF in erythroid cells.

Authors:  Karen J Quadrini; Eugenia Gruzglin; James J Bieker
Journal:  Exp Cell Res       Date:  2008-02-20       Impact factor: 3.905

2.  Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching.

Authors:  D O'Neill; J Yang; H Erdjument-Bromage; K Bornschlegel; P Tempst; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

Review 3.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

Review 4.  The multifunctional role of EKLF/KLF1 during erythropoiesis.

Authors:  Miroslawa Siatecka; James J Bieker
Journal:  Blood       Date:  2011-05-25       Impact factor: 22.113

5.  Altered regulation of beta-like globin genes by a redesigned erythroid transcription factor.

Authors:  Deepa Manwani; Mariann Galdass; James J Bieker
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

Review 6.  Advances in the understanding of haemoglobin switching.

Authors:  Vijay G Sankaran; Jian Xu; Stuart H Orkin
Journal:  Br J Haematol       Date:  2010-03-01       Impact factor: 6.998

7.  Beta-globin locus control region HS2 and HS3 interact structurally and functionally.

Authors:  David A Jackson; Jennifer C McDowell; Ann Dean
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

8.  Context-dependent EKLF responsiveness defines the developmental specificity of the human epsilon-globin gene in erythroid cells of YAC transgenic mice.

Authors:  K Tanimoto; Q Liu; F Grosveld; J Bungert; J D Engel
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

9.  A global role for EKLF in definitive and primitive erythropoiesis.

Authors:  Denise Hodge; Elise Coghill; Janelle Keys; Tina Maguire; Belinda Hartmann; Alasdair McDowall; Mitchell Weiss; Sean Grimmond; Andrew Perkins
Journal:  Blood       Date:  2005-12-27       Impact factor: 22.113

10.  Comparative study of proteome between primary cancer and hepatic metastatic tumor in colorectal cancer.

Authors:  Bo Yu; Shi-Yong Li; Ping An; Ying-Nan Zhang; Zhen-Jia Liang; Shu-Jun Yuan; Hui-Yun Cai
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.